ESPE Abstracts (2019) 92 P3-200

ESPE2019 Poster Category 3 Pituitary, Neuroendocrinology and Puberty (27 abstracts)

Extreme Short Stature and Neurological Impairment in a 17-Year-Old Male with Untreated Combined Pituitary Hormone Deficiency Due to POU1F1 Mutation

Hussein Majdoub 1 , Serge Amselem 2 , Dani Bercovich 3 , Shoshana Rath 4 & Yardena Tenenbaum-Rakover 4,5


1Pediatric Endocrine Clinic, Clalit health services, Haifa, Israel. 2INSERM U.933 and University Piere et Marie Curie, Hoôpital Armand Trousseau, Paris, France. 3Tel Hai College and GGA - Galilee Genetic Analysis Lab,, Tel Hai, Israel. 4Pediatric Endocrine Institute, Ha 'Emek Medical Center,, Afula, Israel. 5Rappaport Faculty of Medicine, Technion, Haifa, Israel


Introduction: POU1F1 is an essential transcription factor for the differentiation, proliferation and survival of somatotrophs, lactotrophs, and thyrotrophs. Mutations in the POU1F1 gene are characterized by growth hormone (GH), thyrotropin and prolactin deficiencies, commonly presenting with growth retardation and central hypothyroidism. Since the first report in 1992, about 26 mutations have been identified in POU1F1.

Case presentation: We describe a 17-year-old male who presented to our Pediatric Endocrinology clinic with extreme short stature (height 81.7 cm, -9.3 SD), cognitive impairment, deaf-mutism and neurological disabilities. L-thyroxine supplemental therapy, which had been initiated at the age of 6 months but ceased due to non-compliance, was reintroduced at presentation. GH therapy was initiated at 19 years of age, resulting in 42 cm linear growth, to a final height of 124 cm. Sequencing of POU1F1 revealed a previously described homozygous insertion mutation—c.580-581insT (p.Thr194llefs*7)—in exon 4 causing a frameshift that introduces a stop codon 7 amino acids forward, leading to a severely truncated protein lacking the homeodomain.

Conclusion: This case report sheds light on the natural history of untreated patients with POU1F1 mutations and raises awareness for early diagnosis and adequate treatment of central congenital hypothyroidism and GH deficiency.

Volume 92

58th Annual ESPE (ESPE 2019)

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.